Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor. [electronic resource]
Producer: 20140812Description: e80110 p. digitalISSN:- 1932-6203
- Acute Lung Injury -- immunology
- Animals
- Antigens, CD -- immunology
- Cell Line
- Endothelial Cells -- cytology
- Endothelial Protein C Receptor
- Endothelium, Vascular -- drug effects
- Humans
- Immunoconjugates -- chemistry
- Intercellular Adhesion Molecule-1 -- immunology
- Intercellular Junctions -- drug effects
- Male
- Mice
- Mice, Inbred C57BL
- Molecular Targeted Therapy
- Platelet Endothelial Cell Adhesion Molecule-1 -- immunology
- Protein C -- agonists
- Receptors, Cell Surface -- immunology
- Single-Chain Antibodies -- chemistry
- Thrombomodulin -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.